| Cutaneous reactions to transdermal therapeutic systems. | |
| | |
MedLine Citation:
|
PMID: 21781635 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Transdermal therapeutic systems (TTSs) are commonly used to treat many diverse medical conditions. There are several advantages to this form of drug delivery; however, adverse cutaneous reactions are common. This review article provides an update on skin reactions due to TTSs containing medications newly available in TTS form, including buprenorphine, diclofenac, lidocaine, oxybutynin, rotigotine, methylphenidate, rivastigmine, teriparatide, and nicardipine. |
| | |
Authors:
|
Andrea Bershow; Erin Warshaw |
Related Documents
:
|
16633745 - How to write an english medical manuscript that will be published and have impact. 6079985 - Mind to mind: persuasion in medical writing. 11620245 - Vernacularisation of medical writing in english: a corpus-based study of scholasticism. 22030205 - First medical contact and physicians' opinion after the implementation of an electronic... 8351305 - The sequencing of psychiatric recommendations. concordance during the process of a psyc... 17424875 - Evaluation of the effects of nasal septal deviation and its surgery on nasal mucociliar... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Dermatitis : contact, atopic, occupational, drug : official journal of the American Contact Dermatitis Society, North American Contact Dermatitis Group Volume: 22 ISSN: 1710-3568 ISO Abbreviation: Dermatitis Publication Date: 2011 Aug |
Date Detail:
|
Created Date: 2011-07-25 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101207335 Medline TA: Dermatitis Country: Canada |
Other Details:
|
Languages: eng Pagination: 193-203 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Alternative Hair-Dye Products for Persons Allergic to para-phenylenediamine.
Next Document: Safety and Efficacy Evaluation of TRUE TEST Panels 1.1, 2.1, and 3.1 in Children and Adolescents.